List of works - Irina Margine

A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates

scientific article

An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans ⬇️

scientific article

Animal models for influenza viruses: implications for universal vaccine development

scientific article

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

scientific article

Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies

scientific article published on 10 April 2013

Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins

scientific article

Divergent H7 immunogens offer protection from H7N9 virus challenge.

scientific article

Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system

scientific article

H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge

scientific article

H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice

scientific article published on 13 February 2013

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

scientific article published on 31 July 2013

Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin

scientific article published on 22 May 2013

Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.

scientific article published on January 2013

Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes

scientific article

NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge

scientific article

One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.

scientific article

Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity

scientific article

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses

scientific article published on 28 May 2015

List of works by Irina Margine

A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates

An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans ⬇️

Animal models for influenza viruses: implications for universal vaccine development

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies

Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins

Divergent H7 immunogens offer protection from H7N9 virus challenge.

Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system

H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge

H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin

Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.

Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes

NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge

One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.

Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses